Showing results (1191-1200 of 1,252) with videos related to

Sort By:
Pageof 126
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Oncotarget|May 19, 2016
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelTsion Zewdu Minas, Didier Surdez, Tahereh Javaheri, et al.
Science Translational Medicine|June 14, 2023
Gut microbiome composition may be an indicator of preclinical Alzheimer's diseaseAura L Ferreiro, JooHee Choi, Jian Ryou, et al.
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Nature|July 27, 2018
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelinationZita Hubler, Dharmaraja Allimuthu, Ilya Bederman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 30, 2015
Provision and consumption of alcohol-based hand rubs in European hospitalsS Hansen, F Schwab, P Gastmeier, et al.
Lancet (London, England)|April 20, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsPaul E Sax, David Wohl, Michael T Yin, et al.
Cell Death & Disease|July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease|August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Journal of Virology|January 11, 2001
Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motifM A Altfeld, B Livingston, N Reshamwala, et al.
Pageof 126